Calistri Paolo, De Clercq Kris, Gubbins Simon, Klement Eyal, Stegeman Arjan, Cortiñas Abrahantes José, Marojevic Drago, Antoniou Sotiria-Eleni, Broglia Alessandro
EFSA J. 2020 Feb 27;18(2):e06010. doi: 10.2903/j.efsa.2020.6010. eCollection 2020 Feb.
In 2019, no lumpy skin disease (LSD) outbreaks were reported in South-Eastern Europe, the mass vaccination regional campaign with homologous LSD vaccine continued for the fourth year with over 1.8 million bovines vaccinated in the region, preventing further outbreaks since 2016. LSD outbreaks were reported in Turkey, including western Turkey, in Russia and in eastern Asia affecting China, Bangladesh and India for the first time. The use of homologous vaccine should be considered in the countries still affected in order to eliminate the virus. Besides passive surveillance, which is implemented in all the countries, active surveillance for early detection based on clinical examination could be conducted ideally during April-October every 5 weeks in at-risk areas, based on possible re-emergence or re-introduction from affected neighbouring countries. Active surveillance for proving disease freedom could be based on serological testing (enzyme-linked immunosorbent assay (ELISA)) targeting 3.5% seroprevalence and conducted on a random sample of cattle herds on non-vaccinated animals. LSD re-emerged in Israel in 2019, after vaccination became voluntary. This shows that, if the virus is still circulating in the region, the reduced protection might result in re-emergence of LSD. In case of re-emergence, a contingency plan and vaccine stockpiling would be needed, in order to react quickly. From a study performed in Israel to test side effects of live-attenuated homologous LSD vaccine, milk production can be reduced during 7 days after vaccination (around 6-8 kg per cow), without a significant loss in the 30 days after vaccination. Research needs should be focused on the probability of transmission from insect to bovine, the virus inactivation rate in insects, the collection of baseline entomological data, the capacity of vector species in LSDV transmission linked to studies on their abundance and the control of being the most important vector in LSD transmission.
2019年,东南欧未报告结节性皮肤病(LSD)疫情,使用同源LSD疫苗的大规模区域疫苗接种运动连续第四年开展,该地区超过180万头牛接种了疫苗,自2016年以来预防了进一步的疫情爆发。土耳其(包括土耳其西部)、俄罗斯以及东亚的中国、孟加拉国和印度首次报告了LSD疫情。仍受疫情影响的国家应考虑使用同源疫苗以消除病毒。除了所有国家都实施的被动监测外,基于临床检查的主动监测以便早期发现,理想情况下应于每年4月至10月期间,每5周在高危地区开展一次,这是基于可能从受影响邻国再次出现或重新传入病毒的情况。用于证明无病状态的主动监测可基于血清学检测(酶联免疫吸附测定(ELISA)),目标血清阳性率为3.5%,并在未接种疫苗动物的牛群随机样本上进行。2019年,在疫苗接种变为自愿性之后,LSD在以色列再次出现。这表明,如果病毒仍在该地区传播,保护水平降低可能导致LSD再次出现。万一疫情再次出现,将需要应急计划和疫苗储备,以便迅速做出反应。根据在以色列进行的一项测试减毒活同源LSD疫苗副作用的研究,接种疫苗后7天内牛奶产量可能会降低(每头奶牛约6 - 8公斤),但接种后30天内不会有显著损失。研究需求应集中在昆虫向牛传播的可能性、病毒在昆虫体内的失活率、基线昆虫学数据的收集、与LSDV传播相关的媒介物种传播能力与其数量研究以及作为LSD传播中最重要媒介的控制方面。